File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Safety of antiobesity drugs

TitleSafety of antiobesity drugs
Authors
Keywordsantiobesity drugs
cetilistat
fenfluramine
lorcaserin
obesity
orlistat
phentermine
rimonabant
sibutramine
tesofensine
Issue Date2013
Citation
Therapeutic Advances in Drug Safety, 2013, v. 4, p. 171-181 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/210756
ISSN
2023 Impact Factor: 3.4
2023 SCImago Journal Rankings: 1.035
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCheung, BMY-
dc.contributor.authorCheung, TT-
dc.contributor.authorSAMARANAYAKE, NR-
dc.date.accessioned2015-06-23T05:49:24Z-
dc.date.available2015-06-23T05:49:24Z-
dc.date.issued2013-
dc.identifier.citationTherapeutic Advances in Drug Safety, 2013, v. 4, p. 171-181-
dc.identifier.issn2042-0986-
dc.identifier.urihttp://hdl.handle.net/10722/210756-
dc.languageeng-
dc.relation.ispartofTherapeutic Advances in Drug Safety-
dc.subjectantiobesity drugs-
dc.subjectcetilistat-
dc.subjectfenfluramine-
dc.subjectlorcaserin-
dc.subjectobesity-
dc.subjectorlistat-
dc.subjectphentermine-
dc.subjectrimonabant-
dc.subjectsibutramine-
dc.subjecttesofensine-
dc.titleSafety of antiobesity drugs-
dc.typeArticle-
dc.identifier.emailCheung, TT: tcheungt@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityCheung, TT=rp01682-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.doi10.1177/2042098613489721-
dc.identifier.pmcidPMC4125319-
dc.identifier.scopuseid_2-s2.0-84890227925-
dc.identifier.hkuros243444-
dc.identifier.volume4-
dc.identifier.spage171-
dc.identifier.epage181-
dc.identifier.eissn2042-0994-
dc.identifier.isiWOS:000443591600004-
dc.identifier.issnl2042-0986-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats